DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Preclinical evaluation of 18F-ML-10 to determine timing of apoptotic response to chemotherapy in solid tumors

Abstract

Here, we investigated 2-(5-fluoro-pentyl)-2-methyl-malonic acid (18F-ML-10) positron emission tomography (PET) imaging of apoptosis posttherapy to determine optimal timing for predicting chemotherapy response in a mouse head/neck xenograft cancer model. BALB/c nude mice (4-8 weeks old) were implanted with UM-SCC-22B tumors. The treatment group received 2 doses of doxorubicin (10 mg/kg, days 0, 2). Small animal 18F-ML-10 PET/computed tomography was performed before and on days 1, 3, and 7 postchemotherapy. Using regions of interest around tumors, 18F-ML-10 uptake change was measured as %ID/g and uptake relative to liver. Terminal Uridine Nick-End Labeling (TUNEL) immunohistochemistry assay was performed using tumor samples of baseline and on days 1, 3, and 7 posttreatment. As a result, treated mice demonstrated increased 18F-ML-10 uptake compared to baseline and controls, and 10 of 13 mice showed tumor volume decreases. All control mice showed tumor volume increases. Tumor-to-liver (T/L) ratios from the control group mice did not show significant change from baseline (P > .05); however, T/L ratios of the treatment group showed significant 18F-ML-10 uptake differences from baseline compared to days 3 and 7 posttreatment (P < .05), but no significant difference at 1 day posttreatment. In conclusion, 2-(5-Fluoro-pentyl)-2-methyl-malonic acid PET imaging has the potential for earlymore » assessment of treatment-induced apoptosis. Timing and image analysis strategies may require optimization, depending on the type of tumor and cancer treatment.« less

Authors:
 [1];  [2];  [3];  [2];  [2];  [2];  [2];  [2];  [2]
  1. Univ. of Pittsburgh, Pittsburgh, PA (United States); Sisli Etfal Training and Research Hospital, Istanbul (Turkey)
  2. Univ. of Pittsburgh, Pittsburgh, PA (United States)
  3. Univ. of Pittsburgh, Pittsburgh, PA (United States); Istanbul Univ., Istanbul (Turkey)
Publication Date:
Research Org.:
Univ. of Pittsburgh, PA (United States)
Sponsoring Org.:
USDOE Office of Science (SC)
OSTI Identifier:
1366738
Grant/Contract Number:  
SC0008833
Resource Type:
Accepted Manuscript
Journal Name:
Molecular Imaging
Additional Journal Information:
Journal Volume: 16; Journal ID: ISSN 1536-0121
Country of Publication:
United States
Language:
English
Subject:
62 RADIOLOGY AND NUCLEAR MEDICINE; molecular imaging; apoptosis; early response; 18F-ML-10; PET

Citation Formats

Demirci, Emre, Ahmed, Rafay, Ocak, Meltem, Latoche, Joseph, Radelet, April, DeBlasio, Nicole, Mason, N. Scott, Anderson, Carolyn J., and Mountz, James M. Preclinical evaluation of 18F-ML-10 to determine timing of apoptotic response to chemotherapy in solid tumors. United States: N. p., 2017. Web. doi:10.1177/1536012116685941.
Demirci, Emre, Ahmed, Rafay, Ocak, Meltem, Latoche, Joseph, Radelet, April, DeBlasio, Nicole, Mason, N. Scott, Anderson, Carolyn J., & Mountz, James M. Preclinical evaluation of 18F-ML-10 to determine timing of apoptotic response to chemotherapy in solid tumors. United States. https://doi.org/10.1177/1536012116685941
Demirci, Emre, Ahmed, Rafay, Ocak, Meltem, Latoche, Joseph, Radelet, April, DeBlasio, Nicole, Mason, N. Scott, Anderson, Carolyn J., and Mountz, James M. Tue . "Preclinical evaluation of 18F-ML-10 to determine timing of apoptotic response to chemotherapy in solid tumors". United States. https://doi.org/10.1177/1536012116685941. https://www.osti.gov/servlets/purl/1366738.
@article{osti_1366738,
title = {Preclinical evaluation of 18F-ML-10 to determine timing of apoptotic response to chemotherapy in solid tumors},
author = {Demirci, Emre and Ahmed, Rafay and Ocak, Meltem and Latoche, Joseph and Radelet, April and DeBlasio, Nicole and Mason, N. Scott and Anderson, Carolyn J. and Mountz, James M.},
abstractNote = {Here, we investigated 2-(5-fluoro-pentyl)-2-methyl-malonic acid (18F-ML-10) positron emission tomography (PET) imaging of apoptosis posttherapy to determine optimal timing for predicting chemotherapy response in a mouse head/neck xenograft cancer model. BALB/c nude mice (4-8 weeks old) were implanted with UM-SCC-22B tumors. The treatment group received 2 doses of doxorubicin (10 mg/kg, days 0, 2). Small animal 18F-ML-10 PET/computed tomography was performed before and on days 1, 3, and 7 postchemotherapy. Using regions of interest around tumors, 18F-ML-10 uptake change was measured as %ID/g and uptake relative to liver. Terminal Uridine Nick-End Labeling (TUNEL) immunohistochemistry assay was performed using tumor samples of baseline and on days 1, 3, and 7 posttreatment. As a result, treated mice demonstrated increased 18F-ML-10 uptake compared to baseline and controls, and 10 of 13 mice showed tumor volume decreases. All control mice showed tumor volume increases. Tumor-to-liver (T/L) ratios from the control group mice did not show significant change from baseline (P > .05); however, T/L ratios of the treatment group showed significant 18F-ML-10 uptake differences from baseline compared to days 3 and 7 posttreatment (P < .05), but no significant difference at 1 day posttreatment. In conclusion, 2-(5-Fluoro-pentyl)-2-methyl-malonic acid PET imaging has the potential for early assessment of treatment-induced apoptosis. Timing and image analysis strategies may require optimization, depending on the type of tumor and cancer treatment.},
doi = {10.1177/1536012116685941},
journal = {Molecular Imaging},
number = ,
volume = 16,
place = {United States},
year = {Tue Jan 10 00:00:00 EST 2017},
month = {Tue Jan 10 00:00:00 EST 2017}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record

Citation Metrics:
Cited by: 12 works
Citation information provided by
Web of Science

Save / Share:

Works referenced in this record:

Single-Photon Emission Computed Tomography Tracers for Predicting and Monitoring Cancer Therapy
journal, January 2014


From the Gla domain to a novel small-molecule detector of apoptosis
journal, February 2009

  • Cohen, Avi; Shirvan, Anat; Levin, Galit
  • Cell Research, Vol. 19, Issue 5
  • DOI: 10.1038/cr.2009.17

Apoptosis Imaging Probe Predicts Early Chemotherapy Response in Preclinical Models: A Comparative Study with 18F-FDG PET
journal, January 2013


Longitudinal PET Imaging of Doxorubicin-Induced Cell Death with 18F-Annexin V
journal, March 2012


Therapeutic Targeting of Apoptotic Pathways in Cancer
journal, October 2006


Detection of apoptosis by PET/CT with the diethyl ester of [18F]ML-10 and fluorescence imaging with a dansyl analogue
journal, January 2014

  • Kadirvel, Manikandan; Fairclough, Michael; Cawthorne, Christopher
  • Bioorganic & Medicinal Chemistry, Vol. 22, Issue 1
  • DOI: 10.1016/j.bmc.2013.11.019

Targeted manipulation of apoptosis in cancer treatment
journal, October 2008


Site-Specific Labeling of Annexin V with F-18 for Apoptosis Imaging
journal, August 2008

  • Li, Xuehe; Link, Jeanne M.; Stekhova, Svetlana
  • Bioconjugate Chemistry, Vol. 19, Issue 8
  • DOI: 10.1021/bc800164d

18F-ML-10, a PET Tracer for Apoptosis: First Human Study
journal, April 2011


Small-Molecule Biomarkers for Clinical PET Imaging of Apoptosis
journal, May 2010


Molecular imaging of cell death in vivo by a novel small molecule probe
journal, October 2006


Cancer Regression by Senescence
journal, May 2007


Challenges and Approaches to Quantitative Therapy Response Assessment in Glioblastoma Multiforme Using the Novel Apoptosis Positron Emission Tomography Tracer F-18 ML-10
journal, February 2014

  • Oborski, Matthew J.; Laymon, Charles M.; Qian, Yongxian
  • Translational Oncology, Vol. 7, Issue 1
  • DOI: 10.1593/tlo.13868

Site-specific 68Ga-labeled Annexin A5 as a PET imaging agent for apoptosis
journal, April 2011


Assessment of response of brain metastases to radiotherapy by PET imaging of apoptosis with 18F-ML-10
journal, June 2012

  • Allen, Aaron M.; Ben-Ami, Miri; Reshef, Ayelet
  • European Journal of Nuclear Medicine and Molecular Imaging, Vol. 39, Issue 9
  • DOI: 10.1007/s00259-012-2150-8

Comparison of radiolabeled isatin analogs for imaging apoptosis with positron emission tomography
journal, August 2009


In Vivo Detection of Apoptosis
journal, June 2008


A Systematic Comparison of 18F-C-SNAT to Established Radiotracer Imaging Agents for the Detection of Tumor Response to Treatment
journal, May 2015


99mTc-HYNIC Annexin-V imaging of primary head and neck carcinoma
journal, January 2004


Detection and Quantification of the Evolution Dynamics of Apoptosis Using the PET Voltage Sensor 18F-Fluorobenzyl Triphenyl Phosphonium
journal, April 2009


Multimodality Imaging of Tumor Response to Doxil
journal, January 2011


First use of 18 F‐labeled ML‐10 PET to assess apoptosis change in a newly diagnosed glioblastoma multiforme patient before and early after therapy
journal, February 2014

  • Oborski, Matthew J.; Laymon, Charles M.; Lieberman, Frank S.
  • Brain and Behavior, Vol. 4, Issue 2
  • DOI: 10.1002/brb3.217

Induction of Apoptosis by Cancer Chemotherapy
journal, April 2000

  • Kaufmann, Scott H.; Earnshaw, William C.
  • Experimental Cell Research, Vol. 256, Issue 1
  • DOI: 10.1006/excr.2000.4838

Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics
journal, August 1972

  • Kerr, J. F. R.; Wyllie, A. H.; Currie, A. R.
  • British Journal of Cancer, Vol. 26, Issue 4
  • DOI: 10.1038/bjc.1972.33

Evaluation of [18F]-CP18 as a PET Imaging Tracer for Apoptosis
journal, May 2013


In Vivo Apoptosis Imaging Using Site-Specifically 68Ga-Labeled Annexin V
book, January 2016


Proliferation, cell cycle and apoptosis in cancer
journal, May 2001

  • Evan, Gerard I.; Vousden, Karen H.
  • Nature, Vol. 411, Issue 6835
  • DOI: 10.1038/35077213

Doxorubicin pharmacokinetics after intravenous and intraperitoneal administration in the nude mouse
journal, June 1981

  • Johansen, Peter B.
  • Cancer Chemotherapy and Pharmacology, Vol. 5, Issue 4
  • DOI: 10.1007/BF00434396

Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis
journal, September 1994


Works referencing / citing this record:

Evaluation of apoptosis imaging biomarkers in a genetic model of cell death
journal, February 2019


[18F]ML-10 PET imaging fails to assess early response to neoadjuvant chemotherapy in a preclinical model of triple negative breast cancer
journal, January 2020

  • Jouberton, Elodie; Schmitt, Sébastien; Chautard, Emmanuel
  • EJNMMI Research, Vol. 10, Issue 1
  • DOI: 10.1186/s13550-019-0587-5